Adagrasib,Cetuximab,Afatinib,Pembrolizumab
Eli Lilly,Boehringer Ingelheim,Merck,mirati
['adagrasib']
#asco23 look who's back the update on adagrasib for pts w/ krasg12c-mutated cancers 35% orr across diseases 21 pdac and 12 biliary ca pts enrolled with a 33% and 42% orr respectively and with a pfs of 5.5 mos wonderful, but still room for improvement 
GI Onc at Hopkins, focusing on #PancreaticCancer, #PrecisionMedicine. Striving to improve patient outcomes.
Originator of #TumorBoardTuesday @TumorBoardTues